
TWO YEAR OUTCOMES OF LOW-DOSE VS VERY LOW-DOSE EXTENDED-RELEASE TACROLIMUS / MYCOPHENOLATE MOFETIL IN DE NOVO KIDNEY TRANSPLANTATION: A MULTI-CENTER RANDOMIZED CONTROLLED TRIAL
Author(s) -
Shigeyoshi Yamanaga,
Yoshiki Hidaka,
Yoshihiko Watarai,
Mariko Toyoda,
Chiaki Kawabata,
Toshihide Tomosugi,
Kenta Futamura,
Manabu Okada,
Makoto Tsujita,
Takahisa Hiramitsu,
Norihiko Goto,
Shunji Narumi,
Takahiro Kobayashi
Publication year - 2020
Publication title -
transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.45
H-Index - 204
eISSN - 1534-6080
pISSN - 0041-1337
DOI - 10.1097/01.tp.0000701888.18995.42
Subject(s) - tacrolimus , medicine , basiliximab , urology , calcineurin , transplantation , randomized controlled trial , renal function , mycophenolic acid , kidney transplantation , single center , gastroenterology , creatinine